During the past decade, Liuzhou Worker's Hospital conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 1 clinical trials were completed, i.e. on average, 3.7% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 1 clinical trials were completed. i.e. 5.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Liuzhou Worker's Hospital" #1 sponsor was "Bayer" with 2 trials, followed by "Chia Tai Tianqing Pharmaceutical Group Co., Ltd." with 2 trials sponsored, "Shanghai Junshi Bioscience Co., Ltd." with 2 trials sponsored, "Betta Pharmaceuticals Co., Ltd." with 1 trials sponsored and "Bio-Thera Solutions" with 1 trials sponsored. Other sponsors include 17 different institutions and companies that sponsored additional 27 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Liuzhou Worker's Hospital" #1 collaborator was "Beijing University of Chinese Medicine" with 2 trials as a collaborator, "China Academy of Chinese Medical Sciences" with 2 trials as a collaborator, "LiuZhou People's Hospital" with 2 trials as a collaborator, "Affiliated Hospital of Guilin University" with 1 trials as a collaborator and "Affiliated Hospital of Youjiang Medical University for Nationalities" with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Liuzhou Worker's Hospital" are "Coronary Heart Disease" (2 trials), "Nasopharyngeal Carcinoma" (2 trials), "Rheumatoid Arthritis" (2 trials), "Acute Coronary Syndrome" (1 trials) and "Acute Ischaemic Stroke" (1 trials). Many other conditions were trialed in "Liuzhou Worker's Hospital" in a lesser frequency.

Most popular intervention types in "Liuzhou Worker's Hospital" are "Drug" (24 trials), "Device" (4 trials), "Biological" (3 trials), "Other" (2 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "240mg anti-PD-1 mAb JS001 Q3W" (1 trials), "3 mg/kg anti-PD-1 mAb JS001 Q2W" (1 trials), "360 mg anti-PD-1 mAb JS001 Q3W" (1 trials) and "Acarbose" (1 trials). Other intervention names were less common.

The vast majority of trials in "Liuzhou Worker's Hospital" are 29 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Liuzhou Worker's Hospital". 4 are not yet recruiting, 6 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Liuzhou Worker's Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Liuzhou Worker's Hospital, 2 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 8 trials that are defined as “Not Applicable".